Table 3 The clinical outcome according to serum E2 values (pg/ml) on ET day
Variables* | Q1 (< 411 pg/ml) (n = 64) | Q2 (411–632 pg/ml) (n = 65) | Q3 (632–905 pg/ml) (n = 65) | Q4 (> 905 pg/ml) (n = 64) | P-value |
|---|---|---|---|---|---|
Women’ age (yr.) | 32.7 ± 4.2 | 32.8 ± 4.1 | 32.3 ± 3.9 | 33.7 ± 4.0 | 0.29 |
Body mass index (kg/m2) | 25.0 ± 2.1 | 25.2 ± 2.0 | 24.7 ± 2.0 | 25.0 ± 2.1 | 0.17 |
Positive pregnancy rate/ET, n (%) | 29 (45.3 %) | 33(50.7 %) | 29 (44.6 %) | 18(28.1 %) | 0.056 |
Blighted ovum rate/ET, n (%) | 7 (10.9 %) | 3 (4.61 %) | 4 (6.15 %) | 3 (4.68 %) | 0.428 |
Clinical pregnancy rate/ET n (%) | 22 (34.4) | 30 (46.2) | 25 (38.5) | 15 (23.4) | 0.056 |
Miscarriage rate/ET n (%) | 2 (9.09 %) | 0 (0 %) | 1 (4 %) | 1 (6.66 %) | 0.431 |
Live birth rate/ET n (%) | 20 (31 %) | 30 (46.2) | 24 (36.9) | 14 (21.9) | 0.042 |